Advertisement
American Association of Endocrine Surgeons| Volume 128, ISSUE 6, P1103-1110, December 2000

Ultrasound and sestamibi scan as the only preoperative imaging tests in reoperation for parathyroid adenomas

  • Daniel L. Feingold
    Affiliations
    Surgical Metabolism Section and the Thoracic Oncology Section, Surgery Branch, National Cancer Institute, and the Nuclear Medicine Department, the Diagnostic Radiology Department, and the Metabolic Disease Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland. Bethesda, Md
    Search for articles by this author
  • H.Richard Alexander
    Affiliations
    Surgical Metabolism Section and the Thoracic Oncology Section, Surgery Branch, National Cancer Institute, and the Nuclear Medicine Department, the Diagnostic Radiology Department, and the Metabolic Disease Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland. Bethesda, Md
    Search for articles by this author
  • Clara C. Chen
    Affiliations
    Surgical Metabolism Section and the Thoracic Oncology Section, Surgery Branch, National Cancer Institute, and the Nuclear Medicine Department, the Diagnostic Radiology Department, and the Metabolic Disease Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland. Bethesda, Md
    Search for articles by this author
  • Steven K. Libutti
    Affiliations
    Surgical Metabolism Section and the Thoracic Oncology Section, Surgery Branch, National Cancer Institute, and the Nuclear Medicine Department, the Diagnostic Radiology Department, and the Metabolic Disease Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland. Bethesda, Md
    Search for articles by this author
  • Thomas H. Shawker
    Affiliations
    Surgical Metabolism Section and the Thoracic Oncology Section, Surgery Branch, National Cancer Institute, and the Nuclear Medicine Department, the Diagnostic Radiology Department, and the Metabolic Disease Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland. Bethesda, Md
    Search for articles by this author
  • William F. Simonds
    Affiliations
    Surgical Metabolism Section and the Thoracic Oncology Section, Surgery Branch, National Cancer Institute, and the Nuclear Medicine Department, the Diagnostic Radiology Department, and the Metabolic Disease Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland. Bethesda, Md
    Search for articles by this author
  • Stephen J. Marx
    Affiliations
    Surgical Metabolism Section and the Thoracic Oncology Section, Surgery Branch, National Cancer Institute, and the Nuclear Medicine Department, the Diagnostic Radiology Department, and the Metabolic Disease Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland. Bethesda, Md
    Search for articles by this author
  • Monica C. Skarulis
    Affiliations
    Surgical Metabolism Section and the Thoracic Oncology Section, Surgery Branch, National Cancer Institute, and the Nuclear Medicine Department, the Diagnostic Radiology Department, and the Metabolic Disease Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland. Bethesda, Md
    Search for articles by this author
  • John L. Doppman
    Affiliations
    Surgical Metabolism Section and the Thoracic Oncology Section, Surgery Branch, National Cancer Institute, and the Nuclear Medicine Department, the Diagnostic Radiology Department, and the Metabolic Disease Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland. Bethesda, Md
    Search for articles by this author
  • David S. Schrump
    Affiliations
    Surgical Metabolism Section and the Thoracic Oncology Section, Surgery Branch, National Cancer Institute, and the Nuclear Medicine Department, the Diagnostic Radiology Department, and the Metabolic Disease Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland. Bethesda, Md
    Search for articles by this author
  • David L. Bartlett
    Affiliations
    Surgical Metabolism Section and the Thoracic Oncology Section, Surgery Branch, National Cancer Institute, and the Nuclear Medicine Department, the Diagnostic Radiology Department, and the Metabolic Disease Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland. Bethesda, Md
    Search for articles by this author

      Abstract

      Background. In an effort to determine an efficient algorithm for the evaluation of patients with parathyroid adenomas in the reoperative setting, we explored the combination of using ultrasound scans (US) and sestamibi scintigraphy as the only preoperative imaging tests. Methods. We analyzed the outcomes of 62 consecutive patients who were treated between January 1995 and May 1999 and who were referred for persistent primary hyperparathyroidism after initial surgical exploration, at which time no abnormal parathyroid glands had been found. Although all patients underwent US, computed tomography scan, magnetic resonance imaging, and sestamibi scan, we analyzed the success of localization and reoperation using only the results of US and sestamibi scan. Results. Sixty-one patients (98%) underwent curative reoperations. The sensitivity, positive predictive value, and accuracy for US were 90%, 86%, and 84%, respectively; the corresponding values for sestamibi imaging were 78%, 94%, and 74%, respectively. In 58 of 62 cases (94%) preoperative US and/or sestamibi scan accurately identified the adenoma. In 3 patients for whom combined US and sestamibi scan were inaccurate, 1 adenoma was found by intraoperative US in the strap muscle; 1 adenoma was found by blind cervical thymectomy, and 1 adenoma was found by planned sternotomy that was based on computed tomography findings. Conclusions. This study supports an algorithm of obtaining US and sestamibi scan as the initial and perhaps only preoperative localization tests for patients with primary hyperparathyroidism after failed operation, at which time no abnormal glands had been found. (Surgery 2000;128:1103-10.)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Lange JR
        • Norton JA
        Surgery for persistent or recurrent primary hyperparathyroidism.
        Current Practices in Surgery. 1992; 4: 56-62
        • Brennan MF
        • Norton JA
        Reoperation for persistent and recurrent hyperparathyroidism.
        Ann Surg. 1985; 201: 40-44
        • Brennan MF
        • Doppman JL
        • Marx SJ
        • Spiegel AM
        • Brown EM
        • Aurbach GD
        Reoperative parathyroid surgery for persistent hyperparathyroidism.
        Surgery. 1978; 83: 669-676
        • Clark OH
        • Stark DD
        • Gooding GAW
        • Moss AA
        • Arnaud SB
        • Newton TH
        • et al.
        Localization procedures in patients requiring reoperation for hyperparathyroidism.
        World J Surg. 1984; 8: 509-521
        • Jaskowiak N
        • Norton JA
        • Alexander HR
        • Doppman JL
        • Shawker T
        • Skarulis M
        • et al.
        A prospective trial evaluating a standard approach to reoperation for missed parathyroid adenoma.
        Ann Surg. 1996; 224: 308-322
        • Kebebew E
        • Clark OH
        Parathyroid adenoma, hyperplasia, and carcinoma: localization, technical details of primary neck exploration, and treatment of hypercalcemic crisis.
        Surg Oncol Clin N Am. 1998; 7: 721-748
        • Miller DL
        • Doppman JL
        • Shawker TH
        • Krudy AG
        • Norton JA
        • Vucich JJ
        • et al.
        Localization of parathyroid adenomas in patients who have undergone surgery: part 1, noninvasive imaging methods.
        Radiology. 1987; 162: 133-137
        • Chen CC
        • Skarulis MC
        • Fraker DL
        • Alexander HR
        • Marx SJ
        • Spiegel AM
        Technetium-99m-sestamibi imaging before reoperation for primary hyperparathyroidism.
        J Nucl Med. 1995; 36: 2186-2191
        • Kern KA
        • Shawker TH
        • Doppman JL
        • Miller DL
        • Marx SJ
        • Spiegel AM
        • et al.
        The use of high-resolution ultrasound to locate parathyroid tumors during reoperations for primary hyperparathyroidism.
        World J Surg. 1987; 11: 579-585
        • Wang C
        Surgical management of primary hyperparathyroidism.
        Curr Probl Surg. 1985; 22: 1-50